Get started
Author

Sahista Vahora

Observed name: S. Vahora
Observed institution: Legend Biotech (United States)
OpenAlex ID: A5117729479
Safety, tolerability, and preliminary efficacy results of a phase 1 study of LB2102, a dnTGFβRII armored DLL3-targeted autologous CAR-T cell therapy, in patients with relapsed or refractory small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC).
2025 · Jacob Sands, Alberto Chiappori, et al. · Journal of Clinical Oncology · 8
Preliminary results of a phase 1 study of LB1908, an autologous Claudin 18.2–targeted chimeric antigen receptor T-cell product, in patients with advanced gastroesophageal adenocarcinoma.
2025 · David Bing Zhen, Christos Fountzilas, et al. · Journal of Clinical Oncology · 6
PDF
Phase 1 study of LB1908, an autologous claudin 18.2-targeted CAR-T cell product, in subjects with advanced gastroesophageal adenocarcinoma.
2026 · David Bing Zhen, Richard T. Maziarz, et al. · Journal of Clinical Oncology · 2
MA11.01 Phase 1 Study of DLL3-Targeted CAR-T Cells Armored With dnTGFBR2 in Small-Cell Lung and Large-Cell Neuroendocrine Cancers
2025 · A.J. Schoenfeld, A. Chiappori, et al. · Journal of Thoracic Oncology · 2
Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report
2026 · Chelsey M. Williams, Susanne M. Arnold, et al. · Frontiers in Oncology · 1
PDF
Preliminary results from an ongoing phase 1 study of LB2102, a dnTGFBR2-armored DLL3-targeted autologous CAR-T cell therapy, in patients with relapsed or refractory SCLC or LCNEC.
2026 · Zhonglin Hao, Alberto Chiappori, et al. · Journal of Clinical Oncology · 1
OA05.02: Phase 1 Study of LB2102, a dnTGFBR2-armored DLL3-targeted Autologous CAR-T Cell Therapy, in Subjects With Relapsed or Refractory SCLC or LCNEC
2026 · A. Chiappori, Z. Hao, et al. · Journal of Thoracic Oncology
EP.13.29 Safety and Efficacy of DLL3 CAR-T Cells Armored With dnTGFBR2 in a Patient With Recurrent Small-Cell Lung Cancer
2025 · Z. Hao, A. Qasrawi, et al. · Journal of Thoracic Oncology
Works count: 8
Citation count: 20
H-index: 2
I10-index:
Year
Topic
Type